Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial

Cited by (460)

Items 201–300 of 460

1. Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications
   John E. McKinnon, Kathleen Maksimowicz‐McKinnon · 2015 · Translational research
2. Immunizations in immunocompromised patients: a guide for dermatologists
   Sophia Mohme, Marc Schmalzing, F. Max Müller, THOMAS M. VOGT, Matthias Goebeler, Johanna Stoevesandt · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
3. Hypersensitivity and Immune-related Adverse Events in Biologic Therapy
   Jamie Lee Waldron, Stephen A. Schworer, Mildred Kwan · 2021 · Clinical Reviews in Allergy & Immunology
4. Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer
   Nicole M. Kuderer, Joshua Aiden Hill, Paul A. Carpenter, Gary H. Lyman · 2021 · Cancer Investigation
5. Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients
   Daryl Ray Cheng, Rebecca Barton, Anthea Louise Greenway, Nigel W. Crawford · 2016 · Expert Review of Vaccines
6. The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis
   Simone Parisi, Alessandra Bortoluzzi, Gian Domenico Sebastiani, Fabrizio Conti, Roberto Felice Caporali, Nicola Ughi, Immacolata Prevete, Alarico Ariani, MARIA MANARA, Greta Carrara et al. · 2019 · Reumatismo
7. Pro: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?
   Ulrich Specks · 2015 · Nephrology Dialysis Transplantation
8. Segurança do uso de terapias biológicas para o tratamento de artrite reumatoide e espondiloartrites
   Lícia Maria Henrique da Mota, Bóris Afonso Cruz, Claiton Viegas Brenol, Daniel Feldman Pollak, Geraldo da Rocha Castelar Pinheiro, Iêda Maria Magalhães Laurindo, Ivânio Alves Pereira, Jozélio Freire de Carvalho, Manoel Barros Bértolo, Marcelo Antônio Amaro Pinheiro et al. · 2014 · Revista Brasileira de Reumatologia
9. Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
   Til Menge, Divyanshu Dubey, Clemens Warnke, Hans-Peter Hartung, Olaf Stüve · 2016 · Expert Review of Neurotherapeutics
10. Immunity 12 years after alemtuzumab in RA: CD5+ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses
    Amy E. Anderson, Alice R. Lorenzi, Arthur G. Pratt, T. Wooldridge, Julie Diboll, Catharien M. U. Hilkens, John Dudley Isaacs · 2012 · Lara D. Veeken
11. The complications of vasculitis and its treatment
    Catherine King, Lorraine Harper, Mark Alan Little · 2018 · Best Practice & Research Clinical Rheumatology
12. A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia
    Peter K. K. Wong, Hanish Bagga, Claire Barrett, Paddy Hanrahan, Doug Johnson, Amel Katrib, Karin S Leder, Mona Marabani, Peta Pentony, John Riordan et al. · 2017 · Internal Medicine Journal
13. Getting the balance right: adverse events of therapy in anti-neutrophil cytoplasm antibody vasculitis
    Limy Wong, Lorraine Harper, Mark Alan Little · 2015 · Nephrology Dialysis Transplantation
14. Characterisation of the clinical and activated T cell response to repeat delayed-type hypersensitivity skin challenges in human subjects, with KLH and PPD, as a potential model to test T cell-targeted therapies
    Alexandra Belson, Tim Schmidt, Disala Fernando, Kelly Hardes, Nicola E. Scott, Sara J Brett, Deborah Clark, João Joaquim de Oliveira, Bill Davis, Simon M. McHugh et al. · 2016 · Inflammation Research
15. Prolonged B Cell Depletion With Rituximab is Effective in Treating Refractory Pulmonary Granulomatous Inflammation in Granulomatosis With Polyangiitis (GPA)
    Scott R Henderson, Susan Jennifer Copley, Charles Dickson Pusey, Philip W. Ind, Alan David Salama · 2014 · Medicine
16. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs in patients with rheumatoid arthritis
    W. Louthrenoo, N. Kasitanon, W. Katchamart, Duangkamol Aiewruengsurat, Parawee Chevaisrakul, P. Chiowchanwisawakit, Pornchai Dechanuwong, P. Hanvivadhanakul, A. Mahakkanukrauh, Siriporn Manavathongchai et al. · 2017 · International Journal of Rheumatic Diseases
17. High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial
    Jack T. Stapleton, Nancy Wagner, Rebecca S. Tuetken, Abbie R. Bellamy, Heather Hill, Sonnie Kim, Patricia L. Winokur · 2020 · Vaccine
18. Stable HLA antibodies following sustained CD19+ cell depletion implicate a long-lived plasma cell source
    Zheng Zhang, Stephen J. Schuster, Simon Francis Lacey, Michael C. Milone, Dimitri S. Monos, Vijay G. Bhoj · 2020 · Blood Advances
19. Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases
    Patricia Richi, José Yuste, Teresa Navío, Laura González-Hombrado, Marina Salido, Israel J. Thuissard, Ana Jiménez-Díaz, Jesús Llorente, Laura Cebrián, L. Lojo et al. · 2021 · Vaccines
20. The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis
    Ithamar Brinkman, Mart A F J van de Laar, Tim Jansen, Eric Nico van Roon · 2011 · Expert Opinion on Drug Safety
21. Pneumococcal antibody protection in patients with autoimmune inflammatory rheumatic diseases with varying vaccination status
    SL Rasmussen, Kurt Fuursted, KA Nielsen, NP Laurberg, M. Sørensen, Steen Kåre Fagerberg, Peter Derek Christian Leutscher, Claus Rasmussen · 2020 · Scandinavian Journal of Rheumatology
22. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic
    Ennio Giulio Favalli, Gabriella Maioli, Martina Biggioggero, Roberto Felice Caporali · 2021 · Expert Review of Clinical Immunology
23. Derisking CD20-therapies for long-term use
    Ide Smets, Gavin Giovannoni · 2021 · Multiple Sclerosis and Related Disorders
24. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases
    Man Fai Law, Rita Ho, Kimmy Wan Tung Law, Carmen Ka Man Cheung · 2021 · World Journal of Hepatology
25. European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
    Susana Otero‐Romero, Christine Lebrun‐Frénay, Saúl Reyes, Maria Pia Amato, Magda Campins, Mauricio Farez, Massimo Filippi, Yael Hacohen, Bernhard Hemmer, Rosa Juuti et al. · 2023 · European Journal of Neurology
26. Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.
    Rüdiger Müller, Reinhard Maier, Katja Höschler, Maria Cristina Fleischmann Alves Zambon, Burkhard Ludewig, Martin Herrmann i, Hendrik Schulze‐Koops, Johannes von Kempis · 2013 · PubMed
27. Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?
    Andreas Kronbichler, David R.W. Jayne · 2015 · Nephrology Dialysis Transplantation
28. Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease
    Huyen‐Tran Nguyen, Phillip Minar, Kimberly Jackson, Patricia C. Fulkerson · 2017 · World Journal of Gastroenterology
29. How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease
    J. Richards, S. Dowell, M. Quiñones, G. Kerr · 2015 · British medical journal
30. Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis
    Marco Krasselt, Christoph Baerwald, Uwe G. Liebert, Olga Seifert · 2019 · Clinical Rheumatology
31. A randomized controlled trial with a delayed‐type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man
    Mahdi Saghari, Pim Gal, Dimitrios Ziagkos, Jacobus Burggraaf, John F. Powell, Nuala Brennan, Robert Rißmann, Martijn B. A. van Doorn, Matthijs Moerland · 2020 · British Journal of Clinical Pharmacology
32. Emerging biotherapies for Sjögren's syndrome
    Gabriel Jaime Tobón, Alain Saraux, Jacques‐Olivier Pers, Pierre Youinou · 2010 · Expert Opinion on Emerging Drugs
33. If and When to Consider Prophylactic Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
    Iris M. Otani, Mark C. Ballow · 2024 · The Journal of Allergy and Clinical Immunology In Practice
34. Acute and chronic inflammatory neuropathies and COVID ‐19 vaccines: Practical recommendations from the task force of the Italian Peripheral Nervous System Association ( ASNP )
    Pietro Emiliano Doneddu, Emanuele Spina, Chiara Briani, Gian Maria Fabrizi, Fiore Manganelli, Eduardo Nobile‐Orazio · 2021 · Journal of the Peripheral Nervous System
35. Pneumococcal Vaccination in Immunocompromised Hosts: An Update
    Claire Froneman, Peter Kelleher, Ricardo Jorge Paixão José · 2021 · Vaccines
36. Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies
    João Marcello de Araújo-Neto, Gabriela Sousa Guimarães, Flavia Ferreira Fernandes, Marcelo Alves Soares · 2022 · Viruses
37. Vaccination and Inflammatory Arthritis: Overview of Current Vaccines and Recommended Uses in Rheumatology
    C.I. Müller-Ladner, Ulf Müller‐Ladner · 2013 · Current Rheumatology Reports
38. Role of vaccinations and prophylaxis in rheumatic diseases
    Despoina Papadopoulou, Christos Tsoulas, Athanasios Tragiannidis, Nikolaos V. Sipsas · 2015 · Best Practice & Research Clinical Rheumatology
39. Failure of pneumococcal immunization during remission induction treatment of ANCA-associated vasculitis: The Pneumovas Pilot 1 study
    Matthieu Groh, Xavier Puéchal, Benjamin Terrier, Claire Le Jeunne, Frédéric Batteux, Odile Launay · 2016 · Joint Bone Spine
40. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell–Mediated CD4 T Cell Responses
    Kuan Yau Wong, Rebecca Baron, Therese A. Seldon, Martina L. Jones, Alison M. Rice, David J. Munster · 2018 · The Journal of Immunology
41. Immunogenicity of sequential 13-valent conjugated and 23-valent unconjugated pneumococcal vaccines in a population of children with lupus
    Mark Gorelik, Araceli Elizalde, Kelli W. Williams, ERICA V. GONZALEZ, Journey Cole · 2018 · Lupus
42. The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
    Yu Bin Seo, Su‐Jin Moon, Chan Hong Jeon, Joon Young Song, Yoon‐Kyoung Sung, Su Jin Jeong, Ki Tae Kwon, Eu Suk Kim, Jae-Hoon Kim, Hyoun‐Ah Kim et al. · 2020 · Infection and Chemotherapy
43. The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to Streptococcus pneumoniae
    Giuseppe Ercoli, Elisa Ramos‐Sevillano, Rie Nakajima, Rafael Ramiro de Assis, Algis Jasinskas, David Goldblatt, Philip Louis Felgner, Gisbert Weckbecker, Jeremy Brown · 2021 · Frontiers in Immunology
44. Rituximab for Rheumatoid Arthritis: A Meta-Analysis and Systematic Review
    Elizabeth R. Volkmann, Harsh Agrawal, Paul Maranian, Daniel E. Furst · 2010 · Clinical Medicine Insights Therapeutics
45. Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system
    Jéfferson Becker, Lis Campos Ferreira, Alfredo Damasceno, Denis Bernardi Bichuetti, Paulo Pereira Christo, Dagoberto Callegaro, Marco Aurélio Lana–Peixoto, Nise Alessandra de Carvalho Sousa, Sérgio Monteiro de Almeida, Tarso Adoni et al. · 2021 · Arquivos de Neuro-Psiquiatria
46. A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
    Stanley Cohen, JEAN SACCUZZO BEEBE, Vishala L. Chindalore, Shunjie Guan, Mina Hassan‐Zahraee, Madhurima Saxena, Li Xi, Craig L Hyde, Sarita Koride, Robert D. Levin et al. · 2024 · Arthritis Research & Therapy
47. Immunization in patients with inflammatory rheumatic diseases
    Κonstantinos Thomas, Dimitrios Vassilopoulos · 2016 · Best Practice & Research Clinical Rheumatology
48. COVID-19 Vaccination in Patients With Multiple Sclerosis on Disease-Modifying Therapy
    Andrew B. Wolf, Enrique Álvarez · 2021 · Neurology Clinical Practice
49. Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases
    Ichiro Kobayashi, Masaaki Mori, Kenichi Yamaguchi, Shuichi Ito, Naomi Iwata, Kenji Masunaga, Naoki Shimojo, Tadashi Ariga, Kenji Okada, Shuji Takei · 2014 · Modern Rheumatology
50. Literature‐based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses
    Valerie Laniosz, Julia Scott Lehman, Gregory A. Poland, David A. Wetter · 2015 · International Journal of Dermatology
51. Long-term repopulation of peripheral B-cell subsets after single and repeated rituximab infusions in patients with rheumatoid arthritis.
    Petra Roll, Zafar Mahmood, Khalid Muhammad, Martin Feuchtenberger, Thomas Dörner, Hans‐Peter Tony · 2015 · PubMed
52. Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden
    Julia Ulrike Holle, Torsten Kubacki, P. Aries, Bernhard Hellmich, Anna Luise Kernder, Christian Kneitz, Peter Lamprecht, Jan Henrik Schirmer, Adrian Schreiber, Peter Berlit et al. · 2025 · Zeitschrift für Rheumatologie
53. A literature review on the patients with autoimmune diseases following vaccination against infections
    Yan Liang, Fanya Meng, Hai‐Feng Pan, Dong‐Qing Ye · 2015 · Human Vaccines & Immunotherapeutics
54. The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non-Hodgkin Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab
    Syed Shahzad Mustafa, Saad Jamshed, Karthik Vadamalai, Allison Clare Ramsey · 2020 · Clinical Lymphoma Myeloma & Leukemia
55. Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis
    Sam Kant, Duvuru Geetha · 2021 · Kidney International
56. Guías para la inmunización del adolescente y adulto en Colombia. Documento de actualización, 2016
    Juan Manuel Gómez Muñoz, Julio César Gómez-Rincón, Abraham Alí-Munive, Carlos Alberto Cano, Paola Ximena Coral Alvarado, Wilfrido Coronell-Rodríguez, Jorge Alberto Cortés, Mónica Duarte Romero, Natalia Londoño Palacio, Ivette Maldonado Chaya et al. · 2016 · Infectio
57. Infectious diseases and immunological markers associated with patients with non-Hodgkin lymphoma treated with rituximab
    Kleber Jordão Souza, Rodrigo Sala Ferro, Luiz Euribel Prestes-Carneiro, Paula Andreia Martins Carrilho, Dewton de Moraes Vasconcelos · 2017 · Immunopharmacology and Immunotoxicology
58. B-cell depleters attenuate the humoral response to SARS-CoV-2 vaccines in multiple sclerosis patients: A case-control study
    William L. Conte · 2021 · Multiple Sclerosis and Related Disorders
59. Impact of Janus kinase inhibitors on antibody response to 13-valent pneumococcal conjugate vaccine in patients with rheumatoid arthritis
    Shunsuke Mori, Yukitaka Ueki, Naruhiko Ishiwada · 2022 · Modern Rheumatology
60. Acquired B-cell deficiency secondary to B-cell-depleting therapies
    Annaliesse Blincoe, Roxane Labrosse, Roshini Sarah Abraham · 2022 · Journal of Immunological Methods
61. Consenso 2012 da Sociedade Brasileira de Reumatologia sobre vacinação em pacientes com artrite reumatoide
    Claiton Viegas Brenol, Lícia Maria Henrique da Mota, Bóris Afonso Cruz, Gecilmara Salviato Pileggi, Ivânio Alves Pereira, Lucila Stange Rezende, Manoel Barros Bértolo, Max Victor Carioca Freitas, Nílzio Antônio da Silva, Paulo Louzada‐Júnior et al. · 2013 · Revista Brasileira de Reumatologia
62. Soluble Markers of Antibody Secreting Cell Function as Predictors of Infection Risk in Rheumatoid Arthritis
    Maria Jimena Gutierrez, Stephen V. Desiderio, Nae‐Yuh Wang, Erika Darrah, Laura C. Cappelli, Gustavo Niño, Michelle Jones, Clifton O. Bingham · 2019 · Journal of Immunology Research
63. Rituximab en artritis reumatoide: una revisión sistemática de eficacia y seguridad
    Blanca Hernández‐Cruz, Miriam García‐Arias, Rafael Ariza Ariza, Emilio Martín Mola · 2011 · Reumatología Clínica
64. Immunization Strategies to Span the Spectrum of Immunocompromised Adults
    Jennifer A. Whitaker · 2020 · Mayo Clinic Proceedings
65. Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
    Ide Smets, Saúl Reyes, David Baker, Gavin Giovannoni · 2021 · Multiple Sclerosis and Related Disorders
66. Rituximab in Rheumatoid Arthritis: A Systematic Review of Efficacy and Safety
    Blanca Hernández‐Cruz, Miriam García‐Arias, Rafael Ariza Ariza, Emilio Martín Mola · 2011 · Reumatología Clínica (English Edition)
67. COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
    Aliya Jaber, Meera H. Patel, Andrew Sylvester, Mary Yarussi, Jennifer Tamar Kalina, Jason P. Mendoza, Robin L. Avila, Matthew A. Tremblay · 2023 · Neurology and Therapy
68. Empfehlungen zum Einsatz von Rituximab bei Patienten mit rheumatoider Arthritis
    Kommission Pharmakotherapie der DGRh, Andrea Rubbert‐Roth, Gerd Rüdiger Burmester, Thomas Dörner, Angela Gause · 2014 · Zeitschrift für Rheumatologie
69. Acute Hepatitis A Virus Infection Without IgM Antibodies to Hepatitis A Virus
    Catherine Chakvetadze, Vincent Olivier Mallet, Laure Gaussec, Laurent Hannoun, Stanislas Pol · 2011 · Annals of Internal Medicine
70. Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases
    Giulio Guerrini, Fabio Franzetti, Roberto Giacomelli, Luca Meroni, Agostino Riva, Carlo Alberto Scirè, Rossana Scrivo, Marcello Tavio, Adriana Agostinone, Paolo Airó et al. · 2020 · Clinical and Experimental Rheumatology
71. Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis
    Johanna Nagel, Goran G. Jonsson, J-Å Nilsson, Chanchai Manuswin, Martin Englund, Tore Saxne, Meliha Crnkic Kapetanovic · 2022 · Vaccine
72. Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine
    Sara K. Tedeschi, Daniel H. Solomon, Yuezhou Chen, Jack Ellrodt, Mary Grace Whelan, Jacklyn Stratton, Keigo Hayashi, Noah B. Whiteman, Lin Chen, Ifeoluwakiisi Adejoorin et al. · 2023 · Seminars in Arthritis and Rheumatism
73. Immune modulation of rheumatoid arthritis.
    D. Pappas, L. Geraldino-Pardilla, J. Bathon · 2011 · Baillière's Best Practice & Research : Clinical Rheumatology
74. Pneumococcal Polysaccharide Vaccines
    John D. Grabenstein, Daniel M. Musher · 2017 · Elsevier eBooks
75. Advancing Biologic Therapy for Refractory Autoimmune Hepatitis
    Albert J. Czaja · 2022 · Digestive Diseases and Sciences
76. Biologics in allergology and clinical immunology: Update on therapies for atopic diseases, urticaria, and angioedema and on safety aspects focusing on hypersensitivity reactions
    Uta Jappe, Karl‐Christian Bergmann, Folke Brinkmann, Valentina Faihs, Aşkın Gülşen, Ludger Klimek, Harald Renz, Sebastian Seurig, Christian Taube, Stephan Traidl et al. · 2024 · Allergologie select
77. Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response
    Stosh Ozog, Elizabeth M. Krantz, Karyn Tindbaek, Julian Munoz, Winnie L. Liu, Clementine Chalal, Sara Pernikoff, Khaleel Yahya, Terry Stevens‐Ayers, Sayan Dasgupta et al. · 2026 · Nature Communications
78. Treatment of ANCA-Associated Vasculitis: New Therapies and a Look at Old Entities
    Ladan Zand, Ulrich Specks, Sanjeev M. Sethi, Fernando Custodio Fervenza · 2014 · Advances in Chronic Kidney Disease
79. Infektionskomplikationen unter Biologika-Therapie bei Patienten mit rheumatoider Arthritis
    Dirk Meyer‐Olson, Kirsten Hoeper, Reinhold Ernst Schmidt · 2010 · Zeitschrift für Rheumatologie
80. Response to Vaccination Against SARS-CoV-2 in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Involvement
    Jack E. Carruthers, James Wells, Arun T. Gupta, Delordson Kallon, Amber Cox, Neuza Pina, Muhammad Magdi Yaqoob, Ravindra Rajakariar · 2022 · Frontiers in Medicine
81. In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review
    Philip George Drennan, Dimitrios Karponis, Duncan B. Richards, Mark Christopher Coles, James N. Fullerton · 2022 · Clinical and Translational Science
82. Vacunas y quimioprofilaxis en artritis reumatoide: ¿podría plantearse un calendario de vacunación?
    Belén Carmen Garrido López, María Victoria Navarro Compán, Federico Navarro Sarabia · 2011 · Reumatología Clínica
83. Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination
    Leher Gumber, Nancy E. Gomez, Georgina V. Hopkins, Davis Tucis, Laura G. Bartlett, Kieran Ayling, Kavita Vedhara, Graham Steers, Mithun Chakravorty, Megan Rutter et al. · 2022 · Lara D. Veeken
84. PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)
    Toby J L Humphrey, Davinder P. S. Dosanjh, Thomas F. Hiemstra, Alex G Richter, Michael Chen-Xu, Wendi Qian, Vivekanand Jha, Katrina Gatley, Rakshya Adhikari, Francis Dowling et al. · 2023 · Trials
85. Consenso de uso de rituximab en artritis reumatoide. Un documento con recomendaciones basadas en la evidencia
    Emilio Martín Mola, Blanca Hernández‐Cruz, Miriam García‐Arias, José María Álvaro‐Gracia, Alejandro Balsa, Juan Jesús Gómez-Reino, José Luís Marenco de la Fuente, Víctor Manuel Martínez-Taboada, Jose Andrés Román Ivorra, Raimón Sanmartí · 2010 · Reumatología Clínica
86. Development of a Delayed-Type Hypersensitivity (DTH) Model in the Cynomolgus Monkey
    Caroline Bouchez, Fr eacute deric Gervais, Renaud Fleurance, Bernard M. Palate, Jean‐Jacques Legrand, Jacques Descotes · 2012 · Journal of Toxicologic Pathology
87. Should anti-CD20 be used as an immune reconstitution therapy?
    Ide Smets, Beatrijs H. A. Wokke, Joost Smolders · 2022 · Multiple Sclerosis Journal
88. Secondary antibody deficiency and immunoglobulin replacement
    Philip Hei Li, Chak-Sing Lau · 2017 · Hong Kong bulletin on rheumatic diseases
89. Management of vaccination in rheumatic disease
    Peter K. K. Wong, Patrick Hanrahan · 2018 · Best Practice & Research Clinical Rheumatology
90. Impfungen in der Rheumatologie
    Martin Feuchtenberger, Reinhard Edmund Voll, Christian Kneitz · 2010 · Zeitschrift für Rheumatologie
91. Impfen bei Immunsuppression: ein Leitfaden für die dermatologische Praxis
    Sophia Mohme, Marc Schmalzing, F. Max Müller, THOMAS M. VOGT, Matthias Goebeler, Johanna Stoevesandt · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
92. SARS-COV-2 vaccine responses in renal patient populations
    Rona Smith, Daniel James Cooper, Rainer Döffinger, Hannah Stacey, Abdulrahman Al-Mohammad, Ian Goodfellow, Stephen G. Baker, Sara E. Lear, Myra D.T. Hosmillo, Nicholas Pritchard et al. · 2022 · BMC Nephrology
93. Characterization of KLH-driven immune responses in clinical studies: A systematic review
    Mahdi Saghari, Manon A. A. Jansen, Hendrika W. Grievink, Robert Rißmann, Matthijs Moerland · 2022 · Frontiers in Drug Discovery
94. A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis
    Deepak Nagra, Katie Bechman, Maryam A. Adas, Zijing Yang, Edward Alveyn, Sujith Subesinghe, Andrew I Rutherford, Victoria B Allen, SAMIR N. PATEL, Mark Russell et al. · 2023 · Vaccines
95. Vacinação em pacientes da Coorte Brasília de artrite reumatoide inicial
    Luciana Feitosa Muniz, Carolina Rocha Silva, Thaís Ferreira Costa, Lícia Maria Henrique da Mota · 2014 · Revista Brasileira de Reumatologia
96. Praktische Probleme bei der Umsetzung von Impfempfehlungen
    Claas Fendler, Ertan Saracbasi, Friedrich Dybowski, F. Heldmann, Joseph M. Braun · 2012 · Zeitschrift für Rheumatologie
97. Redefining multiple sclerosis with CAR-T cell therapy
    Yan-Ruide Li, Yuning Chen, Lili Yang · 2025 · Molecular Therapy
98. Transitioning immunotherapy in neuromyelitis optica spectrum disorder – when and how to switch
    Anastasia Vishnevetsky, Tamara Kaplan, Michael Levy · 2022 · Expert Opinion on Biological Therapy
99. Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients – Lessons learned from the COVID-19 pandemic
    Jakub Wroński, Marzena Ciechomska, Ewa Kuca‐Warnawin · 2023 · Biomedicine & Pharmacotherapy
100. Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells
     Federica Galota, Simone Marcheselli, Sara De Biasi, Lara Gibellini, Francesca Vitetta, Alessia Fiore, Krzysztof Smolik, Giulia De Napoli, Martina Cardi, Andrea Cossarizza et al. · 2025 · Cells